期刊文献+

iPSC-based treatment of age-related macular degeneration (AMD):The path to success requires more than blind faith

原文传递
导出
摘要 Induced pluripotent stem cells(iPSCs)hold great promise for the treatment of human diseases.Two recent first-of-its-kind clinical case reports on the iPSC-based treatment of age-related macular degeneration(AMD)highlight the hopes and challenges associated with the clinical application of iPSCs.
出处 《Genes & Diseases》 SCIE 2017年第2期41-42,共2页 基因与疾病(英文)
基金 Work in the authors’laboratories was supported in part by research grants from the National Institutes of Health(AT004418 to TCH) from the Canadian Institutes of Health Research(MOP 125882 to JH) a Cystic Fibrosis Foundation Therapeutics,Inc.grant(HU15XX0 to JH) a Cystic Fibrosis Canada grant(#3032 to JH).
  • 相关文献

参考文献1

二级参考文献43

  • 1Ong JM, da Cruz L. A review and update on the current status ofstem cell therapy and the retina. Br Med Bull 2012; 102: 133-146[PMID: 22577179 DOI: 10.1093/bmb/lds013].
  • 2Nowak JZ. Age-related macular degeneration (AMD): pathogenesisand therapy. Pharmacol Rep 2006; 58: 353-363 [PMID: 16845209].
  • 3Carr AJ, Smart MJ, Ramsden CM, Powner MB, da Cruz L, CoffeyPJ. Development of human embryonic stem cell therapies for agerelatedmacular degeneration. Trends Neurosci 2013; 36: 385-395#[PMID: 23601133 DOI: 10.1016/j.tins.2013.03.006].
  • 4Rajashekhar G. Mesenchymal stem cells: new players inretinopathy therapy. Front Endocrinol (Lausanne) 2014; 5: 59[PMID: 24795699 DOI: 10.3389/fendo.2014.00059].
  • 5Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa.Lancet 2006; 368: 1795-1809 [PMID: 17113430 DOI: 10.1016/S0140-6736(06)69740-7].
  • 6Yang Z, Li K, Yan X, Dong F, Zhao C. Amelioration of diabeticretinopathy by engrafted human adipose-derived mesenchymalstem cells in streptozotocin diabetic rats. Graefes Arch Clin ExpOphthalmol 2010; 248: 1415-1422 [PMID: 20437245 DOI:10.1007/s00417-010-1384-z].
  • 7Al-Shamekh S, Goldberg JL. Retinal repair with inducedpluripotent stem cells. Transl Res 2014; 163: 377-386 [PMID:24291154 DOI: 10.1016/j.trsl.2013.11.002].
  • 8Toivonen S, Ojala M, Hyysalo A, Ilmarinen T, Rajala K, Pekkanen-Mattila M, nismaa R, Lundin K, Palgi J, Weltner J, TrokovicR, Silvennoinen O, Skottman H, Narkilahti S, Aalto-Set-K,Otonkoski T. Comparative analysis of targeted differentiationof human induced pluripotent stem cells (hiPSCs) and humanembryonic stem cells reveals variability associated with incompletetransgene silencing in retrovirally derived hiPSC lines. Stem CellsTransl Med 2013; 2: 83-93 [PMID: 23341440 DOI: 10.5966/sctm.2012-0047].
  • 9Skottman H. Derivation and characterization of three newhuman embryonic stem cell lines in Finland. In Vitro Cell DevBiol Anim 2010; 46: 206-209 [PMID: 20177999 DOI: 10.1007/s11626-010-9286-2].
  • 10Decembrini S, Koch U, Radtke F, Moulin A, Arsenijevic Y.Derivation of traceable and transplantable photoreceptors frommouse embryonic stem cells. Stem Cell Reports 2014; 2: 853-865[PMID: 24936471 DOI: 10.1016/j.stemcr.2014.04.010].

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部